J.P. Morgan strategist Jared Gross sketches out how small life sciences firms are now well-placed due to higher federal research funding and a more receptive FDA.

Lawsuit alleges hiding cost overruns at Disney+ was a ‘motivating factor’ behind the media giant’s 2020 reorganization.

The NextGen program recognizes the future leaders in institutional investing.

Early data for Q2, including an $8.05 billion transfer by AT&T, keep buy-outs in 2023 far ahead of last year’s pace.

The ACSI will consider recommending that its members vote against current leadership at companies where women comprise less than 30% of the board.